27 April 2025: Articles
From Erysipelas to Epiglottitis: Managing Complications in Invasive Group A Streptococcal Infection
Unusual clinical course
Shuhei Matsumoto ABCDEF 1, Takuya Masuda D 2, Nobuyoshi Minemura ABCDEF 2*, Hiroyoshi Nakajima DE 2, Keita TatsunoDOI: 10.12659/AJCR.947291
Am J Case Rep 2025; 26:e947291
Abstract
BACKGROUND: Group A Streptococcus (GAS, Streptococcus pyogenes) is a gram-positive human-exclusive pathogen responsible for various types of infections. The incidence of invasive GAS infections, which can be severe and are associated with Streptococcal toxic shock syndrome (STSS), is increasing worldwide.
CASE REPORT: A 75-year-old woman with a past medical history of cervical cancer surgically treated 10 years ago and dyslipidemia presented to the Emergency Department with fever, swollen eyelids, and difficulty moving her body. Initially, she was diagnosed with erysipelas based on her typical facial manifestation. Cefazolin was initiated, but it was changed to Ampicillin + Clindamycin due to concerns about invasive GAS and STSS. Despite these antibiotics, her edema deteriorated and her neck became swollen on Day 3. She reported difficulty breathing, and inspiratory stridor subsequently appeared. CT showed facial and pharyngeal edema. We urgently intubated her with a bronchoscope, which revealed a swollen and reddish epiglottis. Her airway symptoms and swollen neck disappeared on Day 11, and she was extubated. On Day 18, her antibiotic treatment was completed.
CONCLUSIONS: We describe a patient with invasive GAS infections whose initial manifestation was typical of erysipelas, but she eventually required intubation due to complicated epiglottitis. Even when GAS disease is treated with antibiotics, it may be difficult to prevent subsequent invasive GAS disease. Regardless of the initial diagnosis and treatment, careful monitoring is vital. When invasive GAS infection is suspected, there is a need to prepare for urgent intervention.
Keywords: Epiglottitis, Erysipelas, Streptococcus pyogenes, Humans, Female, Aged, Streptococcal Infections, Anti-Bacterial Agents
Introduction
Group A Streptococcus (GAS,
Case Report
A 75-year-old woman with a past medical history of cervical cancer, which was surgically treated 10 years ago, and dyslipidemia, presented to the Emergency Department (ED) with fever, swollen eyelids, and difficulty moving her body. Two days before presentation to the ED, she had a 38°C fever, which spontaneously disappeared the next day. At that time, she did not have any concerns about swelling. On the morning of the incident, her family found her collapsed in the living room, experiencing difficulty moving. Otherwise, her history was unremarkable.
On examination, the patient was alert, oriented, and able to follow commands. The following vital signs were obtained: blood pressure 140/88 mmHg, pulse 98 beats/min, respiratory rate 16 breaths/min, temperature 38.3°C, and oxygen saturation 96%. Her face was notable for well-circumscribed erythema and swelling of bilateral eyelids. She had tenderness and difficulty opening her eyes. Purulent discharge was coming from her inner canthus. She had no pain in other areas. Her lungs and heart were clear to auscultation and her abdomen was flat and soft.
Laboratory data (Table 1) revealed neutrophilia and thrombocytopenia (WBC 8500/µL (neutrophils 90.1%), Plt14.3×104/µL). CRP and procalcitonin levels were elevated at 100.9 mg/L and 5.62 ng/mL, respectively. The coagulation panel showed no remarkable changes. Bilateral edema of subcutaneous tissue was seen on non-contrast CT (Figure 1). Sputum culture and blood culture were positive for
The patient was admitted for antibiotic therapy. Because invasive GAS and STSS were confirmed (Table 2), cefazolin (1g q8h) was changed to ampicillin (2g q6h) + clindamycin (600mg q8h) [2,3]. Despite these antibiotics, edema spread to the forehead and malar region. Additionally, non-continuous swelling appeared on her neck on Day 3 in the morning. At the same time, she reported difficulty breathing without stridor. Contrast-enhanced CT (Figure 2) showed facial and pharyngeal edema. Based on her history, an anaphylactic reaction was unlikely. She had no history of trauma, burns, or repeated edema. Additionally, she had not been prescribed any medications that could cause toxicity or angioedema, such as iodine, angiotensin-converting enzyme inhibitors, or non-steroidal anti-inflammatory drugs. Her laboratory data showed normal liver, kidney, and thyroid function. The echocardiogram was within normal limits, and CT scans revealed no tumors. We suspected an invasive GAS-related lesion. Her symptoms deteriorated, and stridor appeared at noon. She was urgently intubated with a bronchoscope (Figure 3). A swollen and reddish epiglottis was observed and epiglottitis was diagnosed. A non-contrast-enhanced CT on Day 8 (Figure 4) indicated improvement in her larynx condition. On Day 11, her airway symptoms and swollen neck disappeared, and she was extubated. On Day 18, her antibiotic treatment was completed.
Discussion
Our patient was a 75-year-old woman with GAS infections whose first manifestation was typical erysipelas but which required intubation due to complicated epiglottitis.
Laryngeal edema can be caused by inflammatory and non-inflammatory diseases. Inflammatory edema results from infections, ulcers, trauma, and burns. Non-inflammatory edema can be triggered by hypersensitivity reactions, venous stasis (due to compression from mediastinal, cervical, and thyroid tumors), aortic aneurysms, angioedema [4], iodism [5], myxedema, and generalized edema associated with conditions like heart failure and liver and kidney dysfunction [6]. In this case, CT showed pharyngeal edema with swollen epiglottis. Sputum and blood culture were positive for
Therefore, we had limitations in our diagnosis, but concomitant surface and blood GABS cultures are more likely to be positive in fulminant cases or in the presence of immune compromise [7]. We thought the concordance between the sputum culture and blood culture results was important information.
Underlying illnesses and medical conditions increase the risk for GAS infection such as skin condition (eg, burns, wounds, and chronic skin breakdown), chronic illness (eg, cirrhosis, obesity, diabetes, and chronic obstructive pulmonary disease), and immunosuppression (eg, sickle cell disease, nephrotic syndrome, human immunodeficiency virus [HIV]/AIDS, and cancer). M protein type is also thought to be one of the risk factors of invasive GAS infection [8]. The M protein is a dimeric coiled-coil fibrillar protein that extends from the bacterial cell wall, and GAS is classified based on the sequence of the 5’ end of the gene encoding the M protein (emm) [9]. Other virulence factors, including streptokinase, SpeB, and superantigens (SpeA, SpeC, and SSA), can worsen invasive GAS. The emm type of GAS can vary from site to site [10] and some virulence factors are common in different GAS diseases. These superantigens have been linked with increased fitness and virulence of contemporary GAS strains causing scarlet fever and invasive disease. Also, the mechanisms of mucosal-associated invariant T cells were recently shown to be highly activated in patients with STSS as host response, and these cells can contribute GAS pharyngitis [9]. These findings indicate that microbiological virulence factors and host responses can explain secondary epiglottitis in this case. However, we could not analyze these factors due to our technological issues. This is another limitation.
In pediatrics, epiglottitis caused by GAS has long been reported [11–13]. Since the introduction of
Initially, our patient was diagnosed with erysipelas based on her typical facial manifestation. However, her deterioration indicated not only localized skin infection but also systemic inflammation. In erysipelas, 4.6% of 607 patients had positive blood cultures, of which 46% were
Conclusions
The case report describes a 75-year-old woman with invasive GAS infections whose initial manifestation was typical erysipelas, but she required intubation due to complicated epiglottitis.
GAS epiglottitis is less common in adults than in pediatric patients, and there are no previously published cases of invasive GAS infections resulting in intubation due to secondary epiglottitis, as observed in the present case. Even when GAS disease is suspected and treated with antibiotics, it may be difficult to prevent subsequent invasive GAS disease [18]. Regardless of the diagnosis upon admission and initial treatment, it is necessary to observe patients carefully, and once invasive GAS infection is suspected, preparation for urgent intervention is required.
Figures
References:
1.. Salamanca BV, Cyr PR, Bentdal YE, Increase in invasive group A streptococcal infections (iGAS) in children and older adults, Norway, 2022 to 2024: Euro Surveill, 2024; 29; 2400242
2.. Stevens DL, Bisno AL, Chambers HF, Executive summary: Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 Update by the Infectious Diseases Society of America: Clin Infect Dis, 2014; 59; 147-59
3.. Ross A, Shoff HW, Toxic shock syndrome: StatPearls [Internet], National Library of Medicine Available from: https://www.ncbi.nlm.nih.gov/books/NBK459345/
4.. Nard J, Wald E, Howrie D, Angioedema caused by streptococcal infection: Pediatr Infect Dis J, 1987; 6; 1065
5.. Sorimachi K, Ikegami Y, Suzuki T, A case of iodism complicated with severe airway stenosis due to pharyngolaryngeal edema: Chudoku Kenkyu, 2013; 26; 305-9
6.. Takahashi H, A case of epiglotic edema due to myxedema: Practica otologica (Kyoto), 1955; 48; 73-76
7.. Glenn GM, Schofield T, Krober M, Group A Streptococcal supraglottitis: Clin Pediatr, 1990; 29; 674-76
8.. Nelson GE, Pondo T, Toews Karrie-Ann, Epidemiology of invasive Group A Streptococcal infections in the United States, 2005–2012: Clin Infect Dis, 2016; 63; 478-86
9.. Brouwer S, Pathogenesis, epidemiology and control of Group A Streptococcus infection: Nat Rev Microbiol, 2023; 21; 431-47
10.. Williamson DA, Smeesters PR, Steer AC: BMC Infect Dis, 2016; 16; 561
11.. Lacroix J, Ahronhei G, Arcand P: Group A Streptococcal supraglottitis, 1986; 109; 20-24
12.. Garland JS, Rice TB, Wendelberger KJ, Havens PL, Group A Streptococcal supraglottitis: Three case reports: Wis Med J, 1991; 90; 55-57
13.. Apuy M, Yock-Corrales A, Moreno AM, Gutierrez A: Cureus, 2022; 14; e24123
14.. Faden H, The dramatic change in the epidemiology of pediatric epiglottitis: Pediatr Emerg Care, 2006; 22; 443-44
15.. Martín MTS, Camacho MR, García CR, Triano MA, Vila LG: An Pediatr, 2023; 99; 438-39
16.. Hakeem H, Aguasvivas M, Dayal L, Patel K, Management dilemma: A case of acute epiglottitis secondary to Group A Streptococcus (GAS): Chest, 2017; 152; A414
17.. Gunderson CG, Martinello RA, A systematic review of bacteremias in cellulitis and erysipelas: J Infect, 2012; 64; 148-55
18.. Erlacher R, Toepfner N, Dressen S, Are invasive Group A Streptococcal infections preventable by antibiotic therapy?: A collaborative retrospective study: Pediatr Infect Dis J, 2024; 43; 931-35
Figures
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133








